A bstract Context: Breast cancer (BC) is the leading cancer amongst Indian women, yet outcome assessment tools remain Western-centric. The BREAST-Q and similar instruments overlook cultural, linguistic, financial and spiritual dimensions critical to Indian survivorship. Aim: We aimed to develop and validate a questionnaire, a patient-reported outcome measure (PROM) for Indian patients, tailored to these unique contexts. Settings and Design: This was a multiphased mixed-method study conducted between 2022 and 2025, integrating qualitative and quantitative methods. Materials and Methods: A total of 200 BC survivors were recruited, 100 for pilot and 100 for validation, with equal arms of breast-conserving surgery and mastectomy. Statistical Analysis: Domains were generated from literature review, expert input and patient narratives, then refined through feedback. Psychometric evaluation included data quality, internal consistency, exploratory factor analysis (EFA) and known-group validity. Results: Internal consistency was excellent across domains (Cronbach’s α = 0.87–0.96). EFA confirmed construct validity Kaiser-Meyer-Olkin = 0.802; Bartlett’s P < 0.001, revealing a stable 5-factor model explaining 58% variance. Patients and healthcare workers consistently rated the tool as culturally relevant, clear and practical, with translations validated in 15 Indian and 1 foreign language. Conclusions: The Amrita Sneham Questionnaire is a reliable, valid and culturally resonant PROM for Indian patients. It fills the gaps left by Western instruments and enables holistic survivorship assessment in oncology practice.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: